Overall rank by patents
#25,346
Across all tracked assignees
USPTO 2015–2025 USPTO PatentsView Foreign Corporation
Tevosol, Inc.
USPTO PatentsView assignee record - 11 granted patents across 5 technology areas, active 2019–2023. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A01N (PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF ; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES ; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS).
11
Total patents granted
5
CPC technology areas
13.9
Avg claims per patent
+75%
5-year filing velocity
The verdict
Tevosol holds 11 US patents across 5 technology areas, rank #25,346 of 50,000 tracked assignees.
- #25,346
- of 50,000 US assignees by volume
- Top 72%
- by Innovation Score (28.6/100)
- 13.9
- avg claims per patent
- +75%
- filing velocity, last 5 yrs
Portfolio overview
Tevosol, Inc. has been granted 11 US utility patents between 2019 and 2023, placing Tevosol, Inc. at rank #25,346 across all assignees tracked by PlainPatent. This portfolio spans 5 distinct Cooperative Patent Classification (CPC) subclasses, averaging 13.9 claims per patent with primary concentration in A01N (PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF ; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES ; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS). As a Foreign Corporation, Tevosol, Inc. is one of the more focused assignees in the PatentsView dataset. By volume, Tevosol sits between Teoco Ltd. (11 patents, rank #25,342) and THE Regents OF THE University OF California, A California Corporation (11 patents, rank #25,350) - the closest US assignees by grant volume. The composite Innovation Score of 28.6/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 7 grants, compared with 4 in the 2015–2019 window, a +75% shift in five-year velocity. An acceleration of this magnitude signals aggressive R&D investment and expanding technical ambition. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Tevosol, Inc.'s 13.9 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while concentration in 5 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Tevosol, Inc. against peers pursuing similar technology classes.
Who files at Tevosol's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Teoco
TEOCO LTD.
11 patents
- Tercel IP
TERCEL IP LIMITED
11 patents
- Terzani S R L
TERZANI S.R.L.
11 patents
- Tetrasun
TETRASUN, INC.
11 patents
- Texas Research In…
TEXAS RESEARCH INTERNATIONAL, INC.
11 patents
- THE GID Group
THE GID GROUP, INC.
11 patents
- THE Kyjen
THE Kyjen company, LLC
11 patents
- THE Regents OF TH…
THE REGENTS OF THE UNIVERSITY OF CALIFORNIA, A CALIFORNIA CORPORATION
11 patents
- Tevosol ◀
TEVOSOL, INC.
11 patents
What this shows Tevosol holds 11 patents at rank #25,346, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Tevosol's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
29 Top 72% higher than 28% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2019–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2019 | 4 | 36.4% |
| 2021 | 3 | 27.3% |
| 2023 | 4 | 36.4% |
Which technologies does Tevosol, Inc. patent most?
Top 5 of 5 technology areas
Patent Moat Analysis
Portfolio Volume Light
Tech Breadth Focused
Claim Depth Standard
Velocity Accelerating
Frequently Asked Questions
How many patents does Tevosol, Inc. hold?
Tevosol, Inc. holds 11 US granted patents filed between 2019 and 2023, spanning 5 technology areas.
What is Tevosol, Inc.'s Innovation Score?
Tevosol, Inc. has an Innovation Score of 28.6 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).
What technology areas does Tevosol, Inc. focus on?
Tevosol, Inc.'s top technology area is A01N (PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF ; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES ; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS) with 11 patents. The company has filed patents in 5 CPC subclasses total.
Is Tevosol, Inc.'s patent filing rate increasing or decreasing?
Tevosol, Inc.'s recent filing velocity is +75% compared to the prior five-year period. This indicates accelerating innovation.
What does claim depth mean for Tevosol, Inc.'s patents?
Tevosol, Inc.'s patents average 13.9 claims each. This falls within the standard range, providing solid legal coverage.
How is the Tevosol, Inc. patent data sourced?
All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.
How to use this portfolio
Tevosol's 11 grants land it in the top 72% by Innovation Score, but volume alone doesn't tell you where the strength sits.
- Read that count against the largest US assignees before treating it as dominance - Tevosol ranks #25,346 of 50,000. Top 50 holders
- Most of this portfolio concentrates in A01N - see who else leads that technology area. A01N leaders
- Check what the four-part Innovation Score actually rewards before comparing it to another company. How the score works
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.